Quality of Life During Neoadjuvant Treatment and After Surgery for Resectable Esophageal Carcinoma

Preoperative CRT with paclitaxel and carboplatin for patients with resectable esophageal cancer had a considerable temporary negative effect on most aspects of HRQoL. Nonetheless, all HRQoL scores were restored or even improved 1 year postoperatively.